Treatment of BPH and pelvic pain in chronic prostatitis with thermobalancing therapy

Benign prostatic hyperplasia or benign prostate enlargement (BPH or BPE) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), defined by pain or discomfort in the pelvic region....

Benign prostatic hyperplasia or benign prostate enlargement (BPH or BPE) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), defined by pain or discomfort in the pelvic region, can be eased these with Thermobalancing therapy and Dr Allen’s Device without side effects.

The scientific article, titled “Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively”, published in a leading International Journal of Quality Innovation, explains how exactly this therapy reduces the size of BPH and chronic pelvic pain and urinary symptoms,

Standard treatments for men with BPH and CP/CPPS have serious side effects
Alpha-blockers, such as tamsulosin (Flomax) and others, can cause retrograde ejaculation and the overall weakness in the body. 5-alpha-reductase inhibitors, such as finasteride and dutasteride, Avodart, Proscar and Propecia, can cause many irreversible side effects: impotence, depression, testicle pain, and even diabetes.
“Drugs and Aging” medical journal has published an article stating that CP/CPPS is caused by a complex of triggers with infectious, immunological, neurological, endocrinological, and psychological etiologies. However, studies targeting these triggers have failed to determine effective treatment strategy for patients with this disorder.

CP/CPPS standard treatment includes risky medications, such as long-term courses of non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen (paracetamol) in combination with antibiotics, alpha-blocking agents and 5-alpha-reductase inhibitors.

NSAIDs, Ibuprofen (Advil, Motrin), Naproxen (Aleve, Anaprox DS, Naprosyn) and others, often cause gastrointestinal (stomach and gut) symptoms, but also serious cardiovascular conditions. The overuse of antibiotics can depress the immune system and lead to antibiotic resistance, skin rash and other allergic reactions, upset stomach, loss of appetite and abdominal pain.

All drugs used for BPH and CP/CPPS standard treatment do not improve the condition of the affected prostate gland, and so their effectiveness is short-lived.
Dr Allen’s Device is a safe solution for chronic prostate diseases
Patented for its unique non-invasive design, Dr Allen’s Device and Thermobalancing therapy have been in use for over 12 years as an effective at-home treatment. No antibiotics, medications, and courses of prostate massage are needed.

Thermobalancing therapy is effective as targets the cause of chronic prostate diseases in the prostate gland. The use of Dr Allen’s Device eliminates micro-hypothermia locally in the affected prostate that eases inflammation and terminates enlargement in the prostate tissue. This therapy is unique as Dr Allen’s Device utilises the body’s own heat to regulate the temperature locally in the prostate gland.

Fine Treatment ensures that the therapeutic Dr Allen’s Device for Prostate Treatment can reach men all over the world. It costs peanuts compared to anything else out there on the market. Moreover, free delivery guaranteed by Royal Mail tracking service is currently on offer. Fine Treatment today is conducting new clinical trials on Thermobalancing therapy and Dr Allen’s Device for patients with kidney stone disease and chronic low back pain.

Dr Allen’s Device is made in the UK and registered with a British medical regulator MHRA. So, its safety is well tested and approved. For more than a decade, Dr. Allen’s Device for Prostate Treatment has been successfully used by thousands of men with BPH chronic pelvic pain and chronic prostatitis across 100 countries.


[adinserter name="Side Widget Banner"] [adinserter name="Guardian_BusinessCategory_300x600"]
[adinserter name="Side Widget Banner"] [adinserter name="Guardian_BusinessCategory_300x600"]

More Stories On Guardian